A program for select organizations to design and deploy governed AI agents on an Agentic Business Network.
TraceLink is selecting a small group of pharmaceutical industry leaders to launch the first OPUS Agents in 2026. This is a strategic co-innovation partnership to design and launch governed, no-code OPUS Agents within agentic business processes.
Learn how OPUS Agents differ from other agentic AI solutions.
We are selecting organizations that:
- Are committed to establishing the structured, multienterprise data foundation required for agents to operate
- Commit to invest the resources required to design and execute against a real OPUS Agent business case
- Identify and will pursue supply chain agentification initiatives sponsored at the executive level
- Will work together to build a quantified business case for deploying a governed, no-code AI agent into live multienterprise processes
Selected companies will work “arm-in-arm” with TraceLink across a structured, multi-phase launch program—from agent ideation through production deployment and business value assessment.
Participation in the Agentic Accelerator Program is limited.
At program completion, participants will:
Design and deploy a live OPUS Agent | At least one OPUS Agent operating on live multienterprise data. |
Create a quantified Business Value Assessment | A complete business value assessment with a quantified ROI. |
Define a change management plan | A feasible human+agent org design and change management plan. |
Receive exclusive access | Innovation partners will receive a discount applied to the standard OPUS Agents pricing model at the time of commercial agreement. |
Apply for the Agentic Accelerator Program
